Hostname: page-component-74656f9884-j7cmm Total loading time: 0 Render date: 2026-11-06T16:08:13.443Z Has data issue: false hasContentIssue false

9-O-acetylated sialic acids enhance entry of virulent Leishmania donovani promastigotes into macrophages

Published online by Cambridge University Press:  15 December 2008

A. GHOSHAL
Affiliation:
Infectious disease and Immunology Division, Indian Institute of Chemical Biology, 4 Raja S.C. Mullick Road, Jadavpur, Kolkata700 032, India
S. MUKHOPADHYAY
Affiliation:
Infectious disease and Immunology Division, Indian Institute of Chemical Biology, 4 Raja S.C. Mullick Road, Jadavpur, Kolkata700 032, India
A. K. CHAVA
Affiliation:
Infectious disease and Immunology Division, Indian Institute of Chemical Biology, 4 Raja S.C. Mullick Road, Jadavpur, Kolkata700 032, India
G. J. GERWIG
Affiliation:
Bijvoet Center, Department of Bio-Organic Chemistry, Utrecht University, Padualaan 8, NL-3584CHUtrecht, The Netherlands
J. P. KAMERLING
Affiliation:
Bijvoet Center, Department of Bio-Organic Chemistry, Utrecht University, Padualaan 8, NL-3584CHUtrecht, The Netherlands
M. CHATTERJEE
Affiliation:
Department of Pharmacology, Institute of Postgraduate Medical Education & Research, 244B A.J.C. Bose Road, Kolkata, 700 020, India
C. MANDAL*
Affiliation:
Infectious disease and Immunology Division, Indian Institute of Chemical Biology, 4 Raja S.C. Mullick Road, Jadavpur, Kolkata700 032, India
*
*Corresponding author: Infectious disease and Immunology Division, Indian Institute of Chemical Biology, 4 Raja S.C. Mullick Road, Jadavpur, Kolkata -700 032, India. Tel: 91 33 2429 8861. Fax: 91 33 2473 5197 or 91 33 2473 0284. E-mail: cmandal@iicb.res.in or Chitra_mandal@yahoo.com
Rights & Permissions [Opens in a new window]

Summary

Distribution of 9-O-acetylated sialic acids (9-O-AcSA) on Leishmania donovani has been previously reported. Considering their role in recognition, the differential distribution of sialic acids especially 9-O-acetylated sialic acids in avirulent (UR6) versus virulent (AG83 and GE1) promastigotes of Leishmania donovani and its role in entry into macrophages was explored. Fluorimetric-HPLC, fluorimetric determination and ELISA revealed 14-, 8- and 5-fold lower sialic acids in UR6 as compared to AG83. Interestingly, on UR6, flow cytometry indicated lower (α2→6)-linked sialoglycoproteins along with minimal 9-O-acetylated sialoglycoproteins by Scatchard analysis. Further, UR6 demonstrated a 9- and 14·5-fold lower infectivity and phagocytic index than AG83. Additionally, de-O-acetylation and de-sialylation of AG83 demonstrated a 3- and 1·5-fold reduced phagocytic index. The role of 9-O-AcSA in entry was further confirmed by pre-blocking the macrophage surface with a cocktail of sugars followed by microscopic quantification. The phagocytic index of AG83 exclusively through 9-O-AcSA was significantly high. Interestingly, AG83 produced higher metacyclic promastigotes containing increased 9-O-AcSA as compared to avirulent UR6 supporting its virulent nature. Taken together; our results conclusively demonstrate the increased presence of 9-O-acetylated sialic acid on promastigotes of virulent Leishmania donovani as compared to avirulent UR6 and their subsequent role in entry within macrophages.

Information

Type
Research Article
Copyright
Copyright © 2008 Cambridge University Press
Figure 0

Fig. 1. Determination of sialic acids. (A) Fluorimetric HPLC. Representative profile of a HPLC chromatogram of fluorescent derivatives of free sialic acids derived from avirulent UR6 promastigotes, buffer used after washing the promastigotes, and medium for culturing UR6 as compared to sialic acids liberated from BSM used as an internal standard is shown. Glycosidically bound sialic acids were subjected to acid hydrolysis, derivatized with 1,2 diamino-4,5-methylenedioxybenzene and analysed as described in the Materials and Methods section. (B) MALDI-TOF mass spectra of HPLC purified Neu5Gc from UR6. The fraction corresponding to the DMB derivatized Neu5Gc peak from avirulent UR6 was collected after fluorimetric-HPLC, lyophilized and placed on the target with an equal volume of matrix (2,5-dihydroxybenzoic acid). All mass spectra were analysed by MALDI-TOF MS in the positive ion mode producing a representative mass spectra profile of fractionated Neu5Gc as shown. (C) A representative mass spectra profile of fractionated Neu5Ac from AG83. The fraction corresponding to the DMB derivatized Neu5Ac peak from virulent AG83 was collected after fluorimetric-HPLC, lyophilized and placed on the target with an equal volume of matrix (2,5-dihydroxybenzoic acid). All mass spectra were analysed by MALDI-TOF MS in the positive ion mode.

Figure 1

Table 1. Quantitative analysis of sialic acids of avirulent and virulent promastigotes by fluorimetric HPLC analysis

Figure 2

Fig. 2. (A–E) Demonstration of differential presence of sialic acids on virulent and avirulent promastigotes of Leishmania donovani by fluorimetric quantitation and flow cytometry. (A) Quantitation of sialic acids. Sialic acids on promastigotes were fluorimetrically quantitated after oxidization with sodium metaperiodate before and after saponification of O-acetyl groups. Results are the mean±s.d. of 4 experiments carried out in duplicate, where, * (asterix) means P<0·01 as compared to UR6. (B) Fluorimetric quantitation of 9-O-AcSA (%). 9-O-AcSA on promastigotes was fluorimetrically quantitated separately before and after saponification. Results are the mean±S.D. of 4 experiments performed in duplicate and * (asterix) means P<0·01 as compared to UR6. (C) Surface expression of (α2→6) and (α2→3) linked sialic acids. AG83 (□) and UR6 (▪) were incubated with biotinylated SNA and MAA and the binding was detected using FITC-streptavidin (Chatterjee et al.2003). Results are the mean±s.d. of 4 experiments performed in duplicate, where * (asterix) means P<0·01 for the binding of AG83 with SNA as compared to UR6. (D) Presence of surface 9-O-AcSA on AG83 promastigotes. Promastigotes (1×106) were incubated with FITC-Achatinin-H and the number of Achatinin-H positive promastigotes was determined by flow cytometry. In parallel, promastigotes were incubated with 9-O-acetyl haemagglutinin esterase of influenza C virus (100 U/ml, 100 μl/ tube) for 1 h at 20°C to remove O-acetyl groups (Vlasak et al.1987; Chatterjee et al.2003). Esterase-treated cells were further exposed to Arthrobacter ureafaciens sialidase (10 U/ml, 50 μl/tube,) to remove the surface sialic acids and processed similarly. (E) Negligible presence of 9-O-AcSA on avirulent UR6. De-O-acetylated and de-sialylated promastigotes were processed similarly. (F–H) Demonstration of sialic acids on virulent and avirulent promastigotes of L. donovani by ELISA and Scatchard analysis. (F) Quantification of 9-O-AcSA on promastigotes by ELISA. Membrane lysates of promastigotes were separately incubated with Achatinin-H and binding was detected colorimetrically. Each point is the mean±s.d. of 4 independent experiments in duplicate, where, * (asterix) means P<0·01 as compared to UR6. (G) Differential binding of 125I-Achatinin-H to AG83 and UR6. Promastigotes (2×106/tube) were incubated for 60 min at 4°C with varying doses of 125I-Achatinin-H, washed and processed. Specificity of binding was determined in parallel competition experiments using a 50-fold excess of unlabelled Achatinin-H and by subsequent separation of the bound and unbound Achatinin-H as described in the text. To determine specific binding of AG83 (◆), the nonspecific (unbound) binding (▪, obtained from 50-fold excess of unlabelled Achatinin-H in the presence of the same amount of 125I-Achatinin-H used in binding) was subtracted from the total binding (□) of 125I-Achatinin-H with promastigotes. In UR6 (◊), a basal level of specific binding is observed. (H) Scatchard plot of the binding of 125I-Achatinin-H with 9-O-AcSA present on AG83 promastigotes. The apparent dissociation constant was obtained from the Scatchard plot in which bound/free was plotted against various amounts of specifically bound Achatinin-H (pM).

Figure 3

Fig. 3. Leishmania-macrophage interactions at physiological temperature. (A) Effect of macrophage: promastigote ratio. Promastigotes from AG83 (▪), GE1 (□) and UR6 (▴) in varying macrophage: promastigote ratio (1:2, 1:5, 1:10, 1:25, and 1:50) was incubated with the macrophages for 45 min at 37°C. The phagocytic index was compared for different ratios by microscopical quantification as described in the Materials and Methods section and expressed as the mean±s.d. of 4 experiments performed in duplicate. (B) Effect of varying incubation time. Promastigotes from AG83 (▪), GE1 (□) and UR6 (▴) were allowed to interact with macrophages at a ratio of 10:1, at 37°C for different time-periods and the phagocytic index was determined as described in the Materials and Methods section. Each point is the mean±s.d. of 4 independent experiments performed in duplicate. (C) Reduced infectivity (%) of de-O-acetylated and de-sialylated virulent promastigotes. Promastigotes of AG83, GE1 and UR6 before (□) and after de-O-acetylation (▪) were incubated with macrophages at the selected macrophage: promastigote ratio of 1:10, for 2 h at 37°C. The promastigotes were treated with 9-O-acetylesterase derived from the HE1 region of the influenza C esterase gene for de-O-acetylation. In parallel, promastigotes were de-sialylated () after incubating with Arthrobacter ureafaciens sialidase under similar conditions and the infectivity (%) was calculated. Error bars show standard deviations of 3 experiments. The reduction in the infectivity (%) of de-O-acetylated virulent strains was compared against untreated control, where # denotes P<0·01 for AG83 and * denotes P<0·05 for GE1. (D) Reduced phagocytic index of de-O-acetylated and de-sialylated virulent promastigotes. Promastigotes of AG83, GE1 and UR6 before (□) and after de-O-acetylation (▪) were subjected to the same experimental conditions as described in Fig. 3C. In parallel, the strains were de-sialylated () after incubating with Arthrobacter ureafaciens sialidase under similar conditions and the phagocytic index was calculated. The phagocytic index of enzyme-treated promastigotes was compared with untreated controls. Error bars show standard deviations of 3 experiments. The reduction in the phagocytic index of de-O-acetylated virulent strains was compared against untreated control, where ## denotes P<0·01 for AG83 and ** denotes P<0·01 for GE1.

Figure 4

Fig. 4. Effect of esterase and sialidase on the entry of promastigotes as demonstrated by confocal microscopy. Representative photomicrographs of entry of promastigotes before and after esterase treatment after 2 h of incubation was processed as described in the Materials and Methods section. Red dots represent DNA binding. The number of promastigotes inside a macrophage was determined by counting 2 small red dots representing nucleus and kinetoplast DNA. Representative profiles of entry of promastigotes of AG83 (A) and GE1 (B) before (Panel a), after esterase (Panel b) and esterase followed by sialidase treatment (Panel c) are shown. A representative image of minimal entry of untreated UR6 with negligible 9-O-AcSA is shown in (C). Column 1, phase photomicrograph. Column 2, detection of propidium iodide-stained fluorescence. Column 3, overlap of 1 and 2.

Figure 5

Table 2. Promastigote-macrophage interaction under different experimental conditions

Figure 6

Fig. 5. Enhanced presence of 9-O-AcSA in metacyclic promastigotes of AG83 as compared to UR6 (A) Increased 9-O-AcSA on metacyclic AG83 promastigotes as demonstrated by agglutination using Achatinin-H. Promastigotes (1×107/ml, 100 μl) in logarithmic, stationary and metacyclic (after purification) phases were incubated with Achatinin-H (▪) at 20–25°C for 30 min, centrifuged and the unagglutinated promastigotes in the supernatant fraction were examined microscopically and counted; accordingly, the degree of agglutination was extrapolated. Achatinin-H-mediated agglutination of promastigotes through binding to surface 9-O-AcSA was confirmed by inhibition in the presence of BSM (). To confirm the stage specificity of the promastigote agglutination mediated by PNA (□) was performed under identical assay conditions. Each point is the average of 3 independent experiments. (B) Minimal presence of 9-O-AcSA on UR6 promastigotes irrespective of different growth phases. Promastigotes of UR6 (1×107/ml, 100 μl) in logarithmic, stationary and metacyclic (after enrichment) phases were similarly incubated with Achatinin-H (▪) and processed as described (A). Achatinin-H-mediated agglutination of promastigotes through binding to surface 9-O-AcSA was confirmed by inhibition in the presence of BSM (). Similar studies were performed with PNA (□). Each point is the average of 3 independent experiments. (C) Increased metacyclic promastigotes (FSClow, R1 population) in AG83 as compared to UR6 by flow cytometry. Promastigotes of AG83 and UR6 in different growth phases like logarithmic, stationary and metacyclics after their enrichment through PNA negative selection as described in the Materials and Methods section were analysed by flow cytometry. The results are shown in terms of the percentage values on FSC versus SSC dot plots representing 1 out of 5 analyses of the promastigote subpopulation corresponding to different cell sizes. The promastigotes gated within R1 corresponding to FSClow intensities comprise of the metacyclics. In parallel, the FSChigh population are the logarithmic promastigotes. (D) Increased 9-O-AcSA on metacyclic promastigotes of virulent AG83 by flow cytometry. The distribution of 9-O-AcSA on the metacyclic promastigotes in R1 of both AG83 and UR6 was determined by the binding of FITC-Achatinin-H plotted in a FITC-Achatinin-H versus side scatter dot plot. The R1 population of metacyclic promastigotes of both AG83 and UR6 was taken as 100% and the Achatinin-H positivity of the population was tested as described in the Materials and Methods section.